产品名称

L-缬氨酸,L-组氨酰-L-组氨酰-L-亮氨酰甘氨酰甘氨酰-L-丙氨酰-L-赖氨酰-L-谷酰胺基-L-丙氨酰甘氨酰-L-a-门冬氨酰-

CAS NO

89105-94-2

中文别名

(3S,6S,12S,15S,18S,21S,30S,33S,36S)-33-((1H-咪唑-4-基)甲基)-36-氨基-15-(3-氨基-3-羰基丙基)-18-(4-氨基丁基)-6-(羧基甲基)-37-(1H-咪唑-4-基)-30-异丁基-2,12,21-三甲基-5,8,11,14,17,20,23,26,29,32,35-十一羰基-4,7,10,13,16,19,22,25,28,31,34-氮杂三十七烷-3-羧酸;Fibrinogen-binding Inhibitor Peptide;Fibrin

英文名称

L-Valine,L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-

英文别名

L-Valine,N-[N-[N-[N-[N2-[N2-[N-[N-[N-[N-(N-L-histidyl-L-histidyl)-L-leucyl]glycyl]glycyl]-L-alanyl]-L-lysyl]-L-glutaminyl]-L-alanyl]glycyl]-L-a-aspartyl]-; 10: PN: JP2002320666SEQID: 10 claimed protein; 125: PN: WO2008058016 SEQID: 126 claimed protein;126: PN: US20030225251 SEQID: 134 claimed sequence; 15: PN: US20070065361SEQID: 16 unclaimed sequence; 16: PN: US20040191249 SEQID: 16 claimed sequence;1: PN: US7049140 SEQID: 1 claimed protein; 1: PN: WO2004069862 SEQID: 1unclaimed sequence; 24: PN: WO2004069875 PAGE: 69 claimed sequence; 29: PN:US7521540 SEQID: 29 unclaimed sequence; 29: PN: WO0155210 SEQID: 29 unclaimedsequence; 32: PN: US6790606 SEQID: 29 unclaimed sequence; 3: PN: WO02072619PAGE: 8 unclaimed sequence; 4: PN: WO2004058305 PAGE: 39 claimed protein; 4:PN: WO2005035002 PAGE: 8 unclaimed sequence; 6: PN: WO0066182 SEQID: 1 claimedprotein; 7: PN: US20060046271 SEQID: 19 unclaimed sequence; Fibrinogen g-chain fragment analog;Fibrinogen-binding inhibitor peptide; Human fibrinogen g-400-411 peptide

分子式

C₅₀H₈₀N₁₈O₁₆

分子量

1189.28

EINECS

熔点

沸点

1809.886 °C at 760 mmHg

毒性

89105-94-2